TET2 and myelodysplastic syndrome: The loss of Tet2 in hematopoietic cells leads to a global loss of 5-hmC and hematopoietic defects, including enhanced hematopoietic stem cell (HSC) self-renewal, myeloid cell expansion, and an increased propensity to develop MDS or acute leukemia (8–13).